#	Pagina
attuale pagina	/open-h2020/projects/226018/index.html
-1	/open-h2020/projects/209360/index.html
-2	/open-dormire/piemonte/ALESSANDRIA/id-600024/bruno.html
-3	/open-h2020/per-topic/sleep/list/index.html
-4	/open-h2020/per-topic/ope/list/index.html
-5	/open-h2020/per-topic/fucoderm/list/index.html
-6	/open-h2020/projects/222180/index.html
-7	/open-h2020/projects/208886/index.html
-8	/open-h2020/per-topic/surmounted/list/index.html
-9	/open-h2020/per-topic/ncv/list/index.html
-10	/open-h2020/projects/221700/index.html

Opendata, web and dolomites

ELDICO ED SIGNED

ELDICO ED, Shaping the Future of Crystallography - The First Pure Electron Diffraction Equipment for Nano-Crystallography

Total Cost €

EC-Contrib. €

Partnership

Views

ELDICO ED project word cloud

Explore the words cloud of the ELDICO ED project. It provides you a very rough idea of what is the project "ELDICO ED" about.

sectors 15 pharmaceutical pure unlocking forecast electron eldico investigations commercial consuming minimum conventional overcomes entering unmeasurable instruments 84 annum overcoming generating 11 shortening lower pharma industry quality institutes atomic 3d employees hitherto screened 90 substances first nano crystallographers 310m ray diffraction impossible 2024 segment 3m drug approval patent market perform techniques issue pending 18bn measured exclusively libraries roi structural compound saving patenting incorporating solid sub 2022 revenues particles marketing time technique limited designed ed nanomaterials mu micro regime faster 10 structure opening company 25 discovery crystal scientific drugs crystalline size characterisation limitations m2 500k diffractometer compounds agrochemicals

Project "ELDICO ED" data sheet

The following table provides information about the project.

Coordinator	ELDICO SCIENTIFIC AG Organization address address: PARK INNOVAARE DELIVERY LAB city: VILLIGEN postcode: 5234 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Switzerland [CH]
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-1
Funding Scheme	SME-1
Starting year	2019
Duration (year-month-day)	from 2019-12-01 to 2020-03-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	ELDICO SCIENTIFIC AG ELDICO SCIENTIFIC AG Organization address address: PARK INNOVAARE DELIVERY LAB city: VILLIGEN postcode: 5234 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	CH (VILLIGEN)	coordinator	50˙000.00

Map

Project objective

Crystal structure determination is still a key issue in pharmaceutical industry. Any compound requires its 3D atomic structure to become “fully characterized” for patenting and marketing approval. However, only the structure of the 10% of all crystalline substances can be determine. The reason: Conventional X-ray diffraction methods are limited because they require crystal of a minimum size of 10 x 10 μm2 and high quality to be measured, which are often time consuming or even impossible to produce. For example in drug discovery the 90% of known, but not fully characterized crystalline compounds, could be rapidly screened for their scientific or commercial potential. Although electron diffraction technique overcomes the limitations of current techniques and allows investigations on nano-crystalline systems, currently there are no commercial instruments dedicated exclusively to electron diffraction. With ELDICO ED we bring to the market the first equipment (patent pending) designed to perform electron diffraction. We offer an electron diffractometer for the analysis of solid compounds enabling crystallographers entering the sub-µm regime for structural analysis of hitherto unmeasurable nano-crystalline particles. That way, they produce important structural information faster, with better quality and at lower cost, overcoming the limitations of X-ray analysis. We are opening up a new market segment: Pure Electron Diffraction. Our technology will impact the pharma sector by unlocking the characterisation of the 500k existing potential new drugs in their libraries, shortening time-to-market by 10%, saving €9-18bn per annum for testing and increasing revenues of up to €310M per annum for every new drug that comes to the market. Similar impact in key sectors like research institutes, agrochemicals and Advanced Nanomaterials is expected. With ELDICO ED we forecast generating revenues of €25.3M (ROI: 11.84) and incorporating 15 employees to our company during 2022-2024

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ELDICO ED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ELDICO ED" are provided by the European Opendata Portal: CORDIS opendata.